Chronic lymphocytic leukemia: Cinderella is becoming a star

Federico Caligaris-Cappio

Research output: Contribution to journalArticlepeer-review


It has taken time for the status of chronic lymphocytic leukemia (CLL) to change within the scientific community. CLL, characterized by the accumulation of seemingly innocent long-lived monoclonal B cells exhibiting mature morphologies, has long been considered the "Cinderella" of blood cancers. CLL is receiving increasing attention from biologists and clinicians, however, because understanding of this disease may elucidate the association between lymphoid tumous and autoimmunity as well as help to define the relationships between antigen stimulation and malignant transformation.

Original languageEnglish
Pages (from-to)67-69
Number of pages3
JournalMolecular medicine (Cambridge, Mass.)
Issue number3-4
Publication statusPublished - Mar 2009

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Molecular Medicine
  • Medicine(all)
  • Genetics(clinical)


Dive into the research topics of 'Chronic lymphocytic leukemia: Cinderella is becoming a star'. Together they form a unique fingerprint.

Cite this